ArticleBMC medicine2011

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Raymond Hutubessy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.